SDEF's Las Vegas Dermatology Seminar
Introducing

Cutaneous Malignancies Forum
Contemporary Issues in Effective Diagnosis and Treatment

November 6, 2019

The Cosmopolitan of Las Vegas, Nevada

Don't Miss Out Register Now!

Approved for 8 AMA PRA Category 1 Credits, ANCC and ACPE Contact Hours!

Jointly Provided by:

In Association With:

EVENT WILL START IN
  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

CO-CHAIRS

avatar Sancy Leachman, MD, PhD

John D. Gray Endowed Chair in Melanoma Research
Professor & Chair, Department of Dermatology
Oregon Health & Science University
Center for Health & Healing CH16D
Portland, OR

avatar Mohammed Kashani-Sabet, MD

Director, Center for Melanoma Research and Treatment
California Pacific Medical Center Research Institute
San Francisco, CA

FACULTY

avatar Maryam Asgari, MD

Associate Professor, Dermatology
Associate Professor, Population Medicine
Harvard Medical School
Director, High Risk Skin Cancer Clinic, Dermatology
Massachusetts General Hospital
Boston, MA

avatar Anna Bar, MD

Assistant Professor
Oregon Health & Science University
Portland, OR

avatar Isaac Brownell, MD, PhD

Head, Cutaneous Development and Carcinogenesis Section
Adjunct Investigator, National Cancer Institute
Bethesda, MD

avatar Madeleine Duvic, MD

Deputy Department Chair
Professor of Medicine and Dermatology
Blanche Bender Professorship in Cancer Research The University of Texas
MD Anderson Cancer Center
Houston, TX

avatar Ervin Epstein, MD

Brown & Toland Physicians
Sutter Medical Network
Oakland, CA

avatar Mark Faries, MD

The Angeles Clinic & Research Institute
Associate Director of Surgical Oncology Experimental Therapeutics
Cedars-Sinai Medical Center
Los Angeles, CA

avatar Laura Ferris, MD, PhD

Associate Professor, University of Pittsburgh Clinical and Translational Science Institute
Director of Clinical Trials, UPMC Department of Dermatology
University of Pittsburgh
Pittsburgh, PA

avatar Youn Kim, MD

Joanne and Peter Haas Jr Professor/Director, Multidisciplinary Cutaneous Lymphoma Program
Stanford University School of Medicine and Stanford Cancer Institute
Stanford, CA

avatar John Kirkwood, MD

Thomas and Sandra Usher Professor of Medicine, Dermatology and Translational Science
Co-Leader, Hillman Melanoma Program
Co-Director, Pediatric Melanoma Program
UPMC Hillman Cancer Institute
Pittsburgh, PA

avatar Michael Migden, MD

Professor
Departments of Dermatology and Head and Neck Surgery
ACGME Fellowship Director: Micrographic Surgery and Dermatologic Oncology
Mohs Surgery Center
The University of Texas - MD Anderson Cancer Center
Houston, TX

avatar Guilherme Rabinowits, MD

Associate Professor of Medicine
Florida International University
Physician Lead, Head and Neck Medical Oncology
Miami Cancer Institute/Baptist Health South Florida
Miami, FL

avatar Merrick Ross, MD

Charles M. McBride Distinguished Professorship in Surgical Oncology
Chief Melanoma Section
Professor, Department of Surgical Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX

avatar Ann Silk, MD

Co-Director of the Merkel Cell Carcinoma Center of Excellence
Dana-Farber Cancer Institute
Boston, MA

THE SCHEDULE

Registration/Breakfast

6:30 – 7:15 AM

Independent Symposium

CME/CE is not provided for this session

7:15 – 8:00 AM

I Introduction – Goals of the meeting

Co-Chairs: Sancy Leachman, MD, PhD/Mohammed Kashani-Sabet, MD

8:15 – 8:30 AM

II Melanoma Session

Epidemiological state of the art

Laura Ferris, MD, PhD

8:30 – 8:50 AM

Melanoma detection: Different tools for different populations

Sancy Leachman MD, PhD

8:50 – 9:10 AM

8th Edition of the AJCC melanoma staging system

Merrick Ross, MD

9:10 – 9:30 AM

Molecular profile testing: New technology to aid treatment

Mohammed Kashani-Sabet, MD

9:30 – 9:50 AM

The surgeon/oncologist role in treatment and follow-up

Merrick Ross, MD

9:50 – 10:10 AM

Medical adjuvant and neoadjuvant therapy for melanoma

John Kirkwood, MD

10:10 – 10:30 AM

Melanoma case study pro/con discussion: Molecular profiling, treatment, and management

Mohammed Kashani-Sabet, MD/Sancy Leachman, MD, PhD/Laura Ferris, MD, PhD/Merrick Ross, MD/John Kirkwood, MD

10:30 – 11:00 AM

Break

11:00 – 11:15 AM

III Keratinocytic Carcinomas Session

Epidemiology and data-based management of keratinocytic carcinomas

Maryam Asgari, MD

11:15 – 11:35 AM

Topical and systemic therapies for basal cell carcinoma

Ervin Epstein, MD

11:35 – 11:55 AM

High-risk squamous cell carcinoma: Surgical treatment and molecular diagnostics

Anna Bar, MD

11:55 AM – 12:15 PM

Lunch

12:15 – 12:30 PM

Independent Symposium

CME/CE is not provided for this session

12:30 – 1:15 PM

Dessert Break

1:15 – 1:30 PM

Keratinocytic Carcinomas Session continued…

Systemic therapy for larger, inoperable keratinocytic carcinomas

Michael R. Migden, MD

1:30 – 1:50 PM

Staging and therapy of cSCC

Guilherme Rabinowits, MD

1:50 – 2:10 PM

cSCC case study presentations and discussion

Guilherme Rabinowits, MD/ Maryam Asgari, MD/Ervin Epstein, MD/Michael Migden, MD

2:10 – 2:40 PM

IV Cutaneous T-Cell Lymphoma Epidemiology and State of the Art Session

Detection and diagnosis

Madeleine Duvic, MD

2:40 – 3:00 PM

Stage-based management approach

Youn Kim, MD

3:00 – 3:20 PM

Treatment in the adjuvant setting

Madeleine Duvic, MD, and Youn Kim, MD

3:20 – 3:40 PM

CTCL case study presentations and discussion

Madeleine Duvic, MD, and Youn Kim, MD

3:40 – 4:10 PM

Break

4:10 – 4:25 PM

V Merkel Cell Carcinoma Session

Epidemiological state of the art

Isaac Brownell, MD, PhD

4:25 – 4:45 PM

Detection and staging

Ann Silk, MD

4:45 – 5:05 PM

Surgical treatment

Mark Faries, MD

5:05– 5:25 PM

Case study presentations and discussion

Ann Silk, MD/Mark Faries, MD/Isaac Brownell, MD, PhD

5:25 – 5:55 PM

Sessions Conclude

5:55 PM

Dinner

5:55 - 6:10 PM

Independent Symposium

CME/CE is not provided for this session

6:10 – 6:55 PM

CME/CE Credit

PHYSICIANS
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Hemedicus and Skin Disease Education Foundation/Global Academy for Medical Education, LLC. Hemedicus is accredited by the ACCME to provide continuing education f or physicians.

Hemedicus designates this live activity for a maximum of 8 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING AND PHARMACY
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Hemedicus. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Pharmacy Education Postgraduate Institute for Medicine designates this continuing education activity for 8 contact hours (.80 CEUs) of the Accreditation Council for Pharmacy Education.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 8 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses to be determined.

location icon
ADDRESS

Global Academy for Medical Education LLC.
7 Century Drive, Suite 301
Parsippany NJ 07054

email icon
FORUM QUESTIONS?

Robin Simak
973-206-8088 (office)
rsimak@hemedicus.com

All content copyright © 2019 Global Academy for Medical Education LLC. All rights reserved. No reproduction, transmission or display is permitted without the written permission.

back to top